Thiazolidinediones peripheral edema

Mudaliar, S., Chang, A.R. and Henry, R.R. (2003) Thiazolidinediones, peripheral edema, and type 2 diabetes incidence, pathophysiology, and clinical implications. Endocrine Practice, 9, 406-416. [Pg.384]

Peripheral edema, which occurred in 6% of patients administered pregabalin in controlled trials (compared to 2% in the placebo arm). The peripheral edema is not a consequence of congestive heart failure, or renal or hepatic insufficiency. The thiazolidinedione class of oral hypoglycemics may increase the risk of fluid retention. In addition, because of limited data, pregabalin should be administered cautiously in patients with NYHA class III or IV cardiac status. [Pg.300]

Theophylline, asthma, 17.2, 18.1, 18.2 Thiazides, see Diuretics Thiazolidinediones cardiovascular reactions, 31.697 musculoskeletal reactions, 32.779 peripheral edema, 29.531 Thiomersal, in vaccines, 28.357 Thiopurines, genetic susceptibility, 31.634 Thyroid hormones, 29.464 Thyroxine, drug interactions, 24.484 Tiaprofenic acid, cystitis, 18.106 TNF, see tumor necrosis factor Tolcapone, 32.289... [Pg.1121]

Big Chemical Encyclopedia